For best results combine with a calorie reduced diet and regular exercise plan
Okay, this part exemplifies how Holly Willough (the host) has no idea what she's talking about and has not done proper research
Semaglutide has a longer half-life (approximately 7 days) compared to tirzepatide (approximately 5 days), which means the wearing-off effect is less pronounced with semaglutide
Asthma is caused by airway inflammation in connection with cytokines such as IL-4 and IL-13 [304, 315]
1,5 In a study published in Nutrients , a whey protein preload significantly increased GLP-1 and peptide YY (PYY) secretion in young obese women, reduced subjective hunger ratings, and improved postprandial glucose and insulin responses compared with a maltodextrin control, although the acute intervention did not directly assess changes in body mass index (BMI)
Here is how the leading options stack up: | Feature | Semaglutide | Tirzepatide | Retatrutide | Liraglutide | |---------|-------------|-------------|-------------|-------------| | **Mechanism** | GLP-1 | GLP-1 + GIP | GLP-1 + GIP + Glucagon | GLP-1 | | **Dosing** | Weekly | Weekly | Weekly | Daily | | **Max Dose** | 2.4mg | 15mg (FDA) | 12mg (trial) | 3mg | | **Avg Weight Loss** | 15-17% | 20-22% | 22-24% | 8-10% | | **FDA Approved** | Yes | Yes | Phase 3 | Yes | | **Oral Option** | Yes (Rybelsus) | No | No | No | ## Semaglutide (Ozempic / Wegovy): The Proven Standard Semaglutide was the medication that transformed obesity treatment from a niche specialty into mainstream medicine
